Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
33.04B | 34.93B | 31.25B | 30.14B | 27.47B | 26.00B | Gross Profit |
6.46B | 6.91B | 6.00B | 5.84B | 5.40B | 5.33B | EBIT |
879.65M | 1.05B | 966.40M | 844.65M | 848.97M | 697.21M | EBITDA |
1.62B | 2.88B | 2.33B | 2.26B | 1.90B | 1.97B | Net Income Common Stockholders |
680.42M | 692.70M | 626.23M | 741.88M | 459.51M | 560.98M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.19B | 10.62B | 10.89B | 10.18B | 10.73B | 11.26B | Total Assets |
39.20B | 38.80B | 35.77B | 31.59B | 29.88B | 32.13B | Total Debt |
9.77B | 9.46B | 6.55B | 5.07B | 4.04B | 4.62B | Net Debt |
3.34B | -1.16B | -4.35B | -5.12B | -6.69B | -6.64B | Total Liabilities |
17.77B | 17.06B | 14.46B | 10.96B | 9.43B | 10.38B | Stockholders Equity |
21.43B | 21.74B | 21.31B | 20.62B | 20.45B | 21.75B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.72B | -2.09B | 404.53M | -1.33B | -221.59M | Operating Cash Flow |
0.00 | 2.94B | 1.90B | 1.50B | 783.89M | 1.27B | Investing Cash Flow |
0.00 | -4.45B | -3.05B | -1.33B | 203.25M | -1.40B | Financing Cash Flow |
0.00 | 2.42B | 1.14B | -135.85M | -881.43M | 576.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥13.92B | 19.67 | 3.03% | 11.76% | 9.97% | ||
75 Outperform | ¥6.62B | 7.09 | 2.36% | 7.72% | 72.38% | ||
72 Outperform | ¥3.56B | 13.11 | 3.66% | 13.49% | 17.08% | ||
69 Neutral | ¥35.02B | 10.81 | 2.50% | 5.01% | -39.78% | ||
67 Neutral | ¥3.17B | 12.38 | 5.30% | 1.87% | -33.27% | ||
66 Neutral | $4.52B | 12.34 | 5.41% | 3.62% | 4.15% | -12.18% | |
62 Neutral | ¥9.48B | 61.02 | ― | 13.52% | -45.02% |